Principal Investigator
Principal Investigator
Alberto Marin-Gonzalez, PhD
Assistant Professor, Department of Cancer Biology
Assistant Investigator, Abramson Family Cancer Research Institute
Core Investigator, Basser Center for BRCA
Core Faculty Member, Penn Center for Genome Integrity
Core Faculty Member, Penn Epigenetics Institute
Member, Abramson Cancer Center
Perelman School of Medicine, University of Pennsylvania
Scientific Background
I was trained as a theoretical physicist but soon became fascinated by biological questions. I obtained a PhD in biophysics at the National Center for Biotechnology (CNB-CSIC) and the Autonomous University of Madrid under the mentorship of Fernando Moreno, Ruben Perez and Guilherme Vilhena. During my PhD, I employed molecular simulations and single-molecule experiments to investigate how DNA sequence influences its structure and flexibility. This work helped define rules governing DNA mechanics and suggested that the physical properties of DNA play a role in chromatin architecture.
For my postdoc, I wanted to understand how DNA folds inside living cells and how this folding influences cellular processes. With this in mind, in 2020, I joined Taekjip Ha's lab at Johns Hopkins University and in 2023 I moved with the lab to Harvard Medical School, where I became co-mentored by Ralph Scully.
At the time, chromatin loops were known to play important roles in gene regulation, but their contribution to DNA repair remained poorly understood. I developed and applied new experimental approaches to address this question. My work revealed that DNA double-strand breaks trigger the formation of chromatin loops that facilitate the homology search - the process by which a broken DNA searches for a matching sequence to use as repair template. Thus, beyond regulating gene expression, chromatin loops also play a key role in preserving genome stability.
My postdoctoral research convinced me that chromatin structure and dynamics are central, yet often overlooked, components of DNA repair. Driven by this insight, I established the Marin Lab at the University of Pennsylvania to investigate how chromatin architecture contributes to genome maintenance and how these mechanisms might be leveraged to improve cancer therapies.